hypovolemic shock
Jump to navigation
Jump to search
Introduction
Shock resulting from loss of >20% of the circulating blood volume.
Etiology
- hemorrhage
- dehydration
- hypoadrenal (Addisonian) crisis
Pathology
- decreased central venous pressure (CVP)
- low cardiac filling pressures
- low cardiac output[3]
- compensatory increase in systemic vascular resistance
Clinical manifestations
- hypotension generally manifests when > 30% of blood volume is lost[4]
- more sensitive indicators of impending shock include:
- anxiety
- tachypnea
- weak peripheral pulse
- cool extremities with pale or mottled skin
Complications
- coagulopathy
- hypercoagulable state with fibrinolysis shutdown
- dilutional coagulopathy due to crystalloid infusion
Management
- general strategies
- rapid volume expansion
- intravenous (IV) fluids
- colloid
- blood products
- prehospital plasma transfusion lowers mortality in unstable trauma patients transported by air[5]
- consider hemodynamic monitoring if coexisting medical problems
- rapid volume expansion
- specific strategies
- correct coagulopathy & thrombocytopenia
- correct electrolyte imbalances
- endoscopy
- interventional radiology
- surgery
- REBOA for pelvic or abdominal bleeding
- avoid vasopressor use in hemorrhagic shock[2]
More general terms
More specific terms
References
- ↑ Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 136
- ↑ 2.0 2.1 Sperry JL et al, Early use of vasopressors after injury: Caution before constriction. J Trauma 2008, 64:9 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18188092
- ↑ 3.0 3.1 Medical Knowledge Self Assessment Program (MKSAP) 14, 17. American College of Physicians, Philadelphia 2006, 2015
- ↑ 4.0 4.1 Rothaus C Hemorrhagic Shock NEJM Resident 360. Jan 24, 2018 https://resident360.nejm.org/content_items/hemorrhagic-shock
- ↑ 5.0 5.1 Sperry JL, Guyette FX, Brown JBet al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med 2018 Jul 26; 379:315 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30044935 https://www.nejm.org/doi/10.1056/NEJMoa1802345